SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-013248
Filing Date
2021-10-18
Accepted
2021-10-18 08:05:41
Documents
12
Period of Report
2021-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K kala-20211014x8k.htm   iXBRL 8-K 35231
  Complete submission text file 0001558370-21-013248.txt   159914

Data Files

Seq Description Document Type Size
2 EX-101.SCH kala-20211014.xsd EX-101.SCH 3152
3 EX-101.LAB kala-20211014_lab.xml EX-101.LAB 16589
4 EX-101.PRE kala-20211014_pre.xml EX-101.PRE 10461
5 EXTRACTED XBRL INSTANCE DOCUMENT kala-20211014x8k_htm.xml XML 5105
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 211327368
SIC: 2834 Pharmaceutical Preparations